Controversy around the morphea

Area of Science:

• Rheumatology
• Dermatology
• Autoimmune Diseases

Background:

• Morphea, or localized scleroderma, is a chronic autoimmune connective tissue disease.
• It presents distinct clinical features, notably the absence of Raynaud's phenomenon, sclerodactyly, or fingertip ulcerations.
• Confusion persists between morphea and systemic sclerosis, impacting patient and physician understanding.

Purpose of the Study:

• To address the nomenclature and classification controversies surrounding morphea.
• To clarify diagnostic criteria and treatment options for morphea and its subtypes.
• To reduce confusion and stress caused by misclassification of morphea.

Main Methods:

• Literature review of current research on morphea.
• Analysis of diagnostic criteria and treatment guidelines.
• Discussion of controversial aspects in morphea classification.

Main Results:

• Morphea is clinically distinct from systemic sclerosis.
• Eosinophilic fasciitis is a recognized subtype requiring specific consideration.
• Debates continue regarding optimal classification and treatment strategies.

Conclusions:

• Clarifying morphea's distinct identity is crucial for accurate diagnosis and management.
• Standardized terminology and classification are needed.
• Further research into evidence-based treatments is warranted.